Monte Rosa Therapeutics Stock (NASDAQ: GLUE) stock price, news, charts, stock research, profile.
Open | $3.73 |
Close | $3.89 |
Volume / Avg. | 251.40K / 216.13K |
Day Range | 3.70 - 4.36 |
52 Wk Range | 2.44 - 8.84 |
Market Cap | $230.54M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 5.94% |
Days to Cover | 8.39 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Monte Rosa Therapeutics (NASDAQ:GLUE) through any online brokerage.
Other companies in Monte Rosa Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Molecular Partners (NASDAQ:MOLN), Renovaro (NASDAQ:RENB), Tectonic Therapeutic (NASDAQ:TECX) and Zentalis Pharma (NASDAQ:ZNTL).
There is no analysis for Monte Rosa Therapeutics.
Monte Rosa Therapeutics has a consensus price target of $17.78.
The stock price for Monte Rosa Therapeutics (NASDAQ: GLUE) is $3.77 last updated Today at July 8, 2024 at 4:28 PM EDT.
There are no upcoming dividends for Monte Rosa Therapeutics.
Monte Rosa Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Monte Rosa Therapeutics.
Monte Rosa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.